‘In Discussion With’

'In Discussion With'

Clinical pharmacy services at The BRIDGE clinic

Written by Christine Clark | 1 Mar 2022

The pharmacy team at The BRIDGE healthcare clinic routinely performs a number of tasks related to effective use and ongoing supply of medicines, ambulatory care clinical pharmacist, Dr […]
'In Discussion With'

The BRIDGE primary care clinic

Written by Christine Clark | 28 Feb 2022

Dr John Clark received the 2021 America Society of Health System Pharmacists award for excellence in pharmacy practice leadership. IMI spoke to him to find out more about […]
'In Discussion With'

Multimodal analgesia – the standard of care

Written by Christine Clark | 23 Feb 2022

Multimodal analgesia is now the standard of care for post-operative pain relief and it can readily be explained to patients, says Dr Alexander Tzabazis, Deputy Director of Anaesthesiology […]
'In Discussion With'

IV non-opioid analgesics and ERAS – the evidence

Written by Christine Clark | 22 Feb 2022

There is now extensive evidence to support the multimodal approach to peri-operative pain relief and the role of intravenous paracetamol and ibuprofen, according to Dr Alexander Tzabazis, Deputy […]
'In Discussion With'

Enhanced recovery after surgery and the maximodal approach

Written by Christine Clark | 21 Feb 2022

Enhanced recovery after surgery (ERAS) offers many advantages including early functional recovery and reduced exposure to opioids. IMI spoke to Dr Alexander Tzabazis, Deputy Director of Anaesthesiology and […]
'In Discussion With'

Implications of findings for disease flare and vaccine reactions in RMD patients

Written by Christine Clark | 8 Feb 2022

With low rates of disease flare and reactogenicity after vaccination, the study findings are reassuring for both patients and clinicians, according to Dr Caoilfhionn Connolly, Rheumatology Fellow at […]
'In Discussion With'

Disease flare and reactogenicity after covid vaccination in RMD patients

Written by Christine Clark | 7 Feb 2022

A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the […]
'In Discussion With'

Primary care network pharmacy – making it work

Written by Christine Clark | 28 Jan 2022

Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN describes how some critical factors need to be taken into account when planning and organising PCN pharmacy […]
'In Discussion With'

RCT of medicines optimisation in general practice

Written by Christine Clark | 27 Jan 2022

Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN explains the positive findings from a randomised controlled trial that evaluated the impact of a medicines’ optimisation […]
'In Discussion With'

What does a PCN pharmacist do?

Written by Christine Clark | 26 Jan 2022

The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary […]
'In Discussion With'

Getting started as a PCN pharmacist

Written by Christine Clark | 25 Jan 2022

The NHS long term plan foresees the establishment of teams of clinical pharmacists in every primary care network (PCN). IMI spoke to Steve Williams, a senior clinical pharmacist […]
'In Discussion With'

What pharmacists need to know about cannabidiol

Written by Christine Clark | 8 Jan 2022

Community pharmacists can be an important source of information about cannabidiol (CBD) but they also need to ensure that the CBD products that they sell are correctly licensed […]